Protagonist Therapeutics
PTGX
PTGX
76 hedge funds and large institutions have $228M invested in Protagonist Therapeutics in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+10
Holders Change %
+15.15%
% of All Funds
1.67%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
19
Increased
29
Reduced
18
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
1
RTW Investments
New York
|
$9.16M |
| 2 |
NHAS
2
Novo Holdings A/S
Hellerup,
Denmark
|
$5.75M |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$47.3M |
| 4 |
BBA
4
Baker Bros. Advisors
New York
|
$14.1M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$2.96M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SSA
76
Schonfeld Strategic Advisors
New York
| – | -$1.23M | -101,800 | Closed |
|
|
WAM
77
Wolverine Asset Management
Chicago,
Illinois
| – | -$968K | -80,000 | Closed |
|
|
FI
78
Fosun International
Hong Kong,
China
| – | -$569K | -47,513 | Closed |
|
79
Marshall Wace
London,
United Kingdom
| – | -$216K | -17,799 | Closed |
|
|
AG
80
Algert Global
San Francisco,
California
| – | -$188K | -15,517 | Closed |
|
|
SAM
81
Sectoral Asset Management
Montreal,
Quebec, Canada
| – | -$138K | -11,400 | Closed |
|
82
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$4K | -304 | Closed |
|
|
TRCT
83
Tower Research Capital (TRC)
New York
| – | -$1K | -75 | Closed |
|